Therapy News and Research

RSS

Rapidly growing nanotechnology firm launches new identity as MIP Discovery

MIP Diagnostics, a leading UK nanotechnology firm has today rebranded to MIP Discovery as the business continues its expansion within the healthcare sector.

From MIP Discovery 19 May 2022

Researchers examine link between long-term use of blood pressure drugs and breast cancer risk

Curtin University researchers will examine if the long-term use of a popular blood pressure medication increased the risk of breast cancer in almost 200,000 women as part of a new project supported by the Federal Government.

19 May 2022

Using diet as a primary intervention to achieve remission of type 2 diabetes in adults

The American College of Lifestyle Medicine has released an expert consensus statement to assist clinicians in achieving remission of type 2 diabetes in adults using diet as a primary intervention.

18 May 2022

Effectiveness of Acceptance Commitment Therapy for autistic individuals has been investigated

A doctoral thesis at Karolinska Institutet in Sweden has investigated whether Acceptance Commitment Therapy (ACT) can be used for individuals with Autism Spectrum Disorder.

18 May 2022

Gestational diabetes mellitus in overweight and obese pregnant women may increase COVID-19 severity

Researchers reported that gestational diabetes mellitus and obesity were associated with severe COVID-19.

18 May 2022

‘That’s just part of aging’: Long covid symptoms are often overlooked in seniors

Nearly 18 months after getting covid-19 and spending weeks in the hospital, Terry Bell struggles with hanging up his shirts and pants after doing the laundry.

18 May 2022

Case report: human breast milk from vaccinated woman clears persistent SARS-CoV-2 infection

A new study published in the journal Viruses aimed to report the effects of plasma infusion and then breastmilk ingestion as a therapy for persistent SARS-CoV-2 infection in a patient with a common variable immunodeficiency (CVID) phenotype.

18 May 2022

Exosomes derived from γδ-T cells synergized with radiotherapy can control nasopharyngeal carcinoma

A research team at LKS Faculty of Medicine, The University of Hong Kong discovered that exosomes derived from γδ-T cells (γδ-T-Exos) synergised with radiotherapy can control nasopharyngeal carcinoma (NPC) by overcoming the radioresistance of NPC cancer stem cells (CSCs) and preserve their tumor-killing and T cell-promoting activities in the immunosuppressive NPC microenvironment.

18 May 2022

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

Imugene Limited, a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient was dosed in a Phase 1 clinical trial evaluating the safety of novel cancer-killing virus CF33-hNIS VAXINIA when used in people with advanced solid tumors.

18 May 2022

The efficacy of CoronaVac against SARS-CoV-2 in cancer patients

In a recent study published in the Journal of Medical Virology, researchers analyzed the efficacy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in preventing SARS-CoV-2 infection among cancer patients.

18 May 2022

Cannabidiol for Parkinson's disease symptom management

Scientists have published a review study in the Journal for Nurse Practitioners that has focussed on various aspects of the use of cannabidiol in Parkinson's.

17 May 2022

New technology may pave the way for development of point-of-care devices and diagnostic tests

Biomarkers are components that may be present in biological samples and are related to specific diseases. Therefore, doctors can analyze biological samples from a patient to check their health condition or to monitor the progress of a specific therapy.

17 May 2022

Patients with COVID-19 pneumonitis and moderate to severe ARDS treated with sildenafil

A new study published in the British Journal of Anaesthesia aimed to determine whether sildenafil could improve gaseous exchange in patients with COVID-19 ARDS with pulmonary hypertension, RV dysfunction, or both.

17 May 2022

Polypharmacy can lead to harmful drug interactions, especially among cancer patients

Here's a scenario so common that it applies to nearly 92 percent of older adults with cancer: An individual comes in for treatment and reports taking several medications that might include a drug for high blood pressure or heart disease, an antidepressant, or something for diabetes.

17 May 2022

Therapy News and Research

Rapidly growing nanotechnology firm launches new identity as MIP Discovery

Researchers examine link between long-term use of blood pressure drugs and breast cancer risk

Using diet as a primary intervention to achieve remission of type 2 diabetes in adults

Effectiveness of Acceptance Commitment Therapy for autistic individuals has been investigated

Gestational diabetes mellitus in overweight and obese pregnant women may increase COVID-19 severity

‘That’s just part of aging’: Long covid symptoms are often overlooked in seniors

Case report: human breast milk from vaccinated woman clears persistent SARS-CoV-2 infection

Exosomes derived from γδ-T cells synergized with radiotherapy can control nasopharyngeal carcinoma

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

The efficacy of CoronaVac against SARS-CoV-2 in cancer patients

Cannabidiol for Parkinson's disease symptom management

New technology may pave the way for development of point-of-care devices and diagnostic tests

Patients with COVID-19 pneumonitis and moderate to severe ARDS treated with sildenafil

Polypharmacy can lead to harmful drug interactions, especially among cancer patients

Using AI to predict heart attacks

Exploring mutational energetics and the role of arginine blockers in COVID-19 treatments

Hormone replacement therapy associated with reduction in mortality from COVID-19

Patients, doctors, insurers agree: Prior approvals for treatment should come faster

Mice live longer with nasal gene therapy

NAVIGATOR trial: Nearly half of asthma patients improved with tezepelumab treatment

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News